Shares of Glenmark Pharmaceuticals rose nearly 3 per cent after the company said one of its deals with Sanofi signed in May,had got US clearance and it has received $25 million upfront payment from the French healthcare giant. At 9.34 a.m.,shares of the company were up 2.15 per cent at Rs 318.60.